Google reported the first confirmed AI-assisted zero-day exploit, raising new concerns about logic flaws, supply chain risk, and containment. AI-assisted hacking has crossed from theory into a ...

First AI zero-day: Google detected the first confirmed AI-created zero-day exploit, aimed at bypassing 2FA in a popular open-source admin tool. Rapid containment: The flaw was disclosed to the vendor ...

It’s July 20, 1969. Neil Armstrong and Buzz Aldrin are about to land on the moon. They will be the first humans to set foot on Earth’s only natural satellite. Suddenly, the onboard computer flashes: ...

There was a time when the idea of Magic: The Gathering crossing over with other franchises felt impossible. Magic just didn’t do that. When The Walking Dead showed up as a mechanically unique Secret ...

“A state of emergency may create breathing room. What matters is what the State does with that time.” Last week I argued that while a state of emergency may temporarily suppress crime, it cannot ...

So, you want to learn Python, huh? It’s a pretty popular language these days, used for all sorts of things like making websites, crunching data, and even AI. The good news is, you don’t need to spend ...

The clinical-stage biotech might have a successful drug on its hands, if a relatively early-stage clinical trial is any indication. Its REC-4881 did very well in the testing. 10 stocks we like better ...

Recently, a friend asked me a question that's been floating around every boardroom and business school: "With AI writing code, does programming still matter?" It's a fair question. Generative AI can ...

This was largely due to news from a rival clincal-stage biotech. Late on Friday, U.K.-based Biodexa announced it had launched a phase 3 clinical trial of its eRapa, an investigational drug that ...

Before market open, Recursion disclosed in a tersely worded regulatory filing with the Securities and Exchange Commission (SEC) that it was taking a series of measures to streamline its operations.